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THE deletion of tumour specific antigens by mouse mammary carcinomata,
transplanted serially within their strain of origin, was described by Woodruff and
Symes (1962). It was suggested that such deletion may be associated with loss
of the point d'appui for the host's immunological defences, and consequent loss
of any restraining effect they may have on the tumour's progress.
In order to test this hypothesis further, a correlation was sought between
deletion of tumour specific antigens and other evidence of increasing malignancy
on the part of the tumour.
MATERIALS AND METHODS
Mice and tumours studied
Highly inbred A-strain mice of both sexes were used throughouttheinvestiga-
tion.
Three mammary carcinomata "A ", "B " and "C ", which arose
spontaneously in A-strain female mice were studied. Tumours "A" and "B"
were those described in the preceding paper (Symes, 1965). Tumour "C"
arose spontaneously in a member of the A-strain colony maintained in this
department.
Scheme of tumour transplantation
The scheme of tumour transplantation was as used for the " normal line ",
described by Symes (1965).
In the case of tumours " A" and " B ", the three mice from each passage of
the " normal line ", which were not killed for assessment of the degree of host
immunological response to the tumour, were allowed to die naturally from their
tumours.
Tumour " C " was similarly maintained by serial transplantation into groups
of 3 isogenic hosts. However in some cases the interval between successive pas-
sages of the tumour was four weeks rather than two, and this longer interval
was reckoned as equivalent to two passages.
Tumours " A " and " B " were maintained throughout in female hosts and
tumour "C " in males.190 M. 0. SYMES
Observations on animals bearing tumour transplants
At weekly intervals the diameter of each tumour was measured to the nearest
millimetre, using a caliper, in two places at right angles to each other, the result
being expressed as a mean diameter.
The mice comprising each passage ofeach tumour were allowed to die naturally
and the day of death for each mouse was recorded.
Where the degree of post-mortem autolysis was not excessive, the mouse was
weighed to the nearest 0 5 g. and the spleen, together with the ipsilateral and
contralateral lymph nodes were removed and weighed to the nearest 0*1 mg.
The relative spleen weight and ipsilateral and contralateral lymph node weights
were then calculated and expressed as described by Symes (1965).
RESULTS
The rate of growth for successive passages of tumours " A , B " and " C
are shown in Fig. 1. It may be seen that the growth rate remained similar for
successive passages of a given tumour.
The time of death among hosts bearing succeeding passages of tumours " A ",
" B " or " C " decreased as shown in Table I.
TABLE 1.-Time ofDeathfor A-Strain Mice Bearing Successive Passages ofA-Strain
Mammnary Carcinornata " A ", " B " or " C
Tumour "A"
Passage No. 2 3 4 5 6
Day Individual 60 71 32 38 45
of values 45 61 25 59 48
death values L 74 32 35
Mean 60 66 30 49 43
Tumour "B"
Passage No. 1 3 4
Day Individual 42 29 22
feath values 5 . 37
Mean 44 32 35
Tumour "C"
Passage No. 1 2 4 5 7
Day Individual 56 61 32 53 35
of values 61 59 43 46 38
death values 54 47 57 4
Mean 57 56 . 44 50 39
It may also be noted that the killing time for early passages of tumour "B"
was markedly less than for corresponding passages of tumours " A " and "C ".
The ipsilateral and contralateral lymph node weights, thymic weights and
relative spleen weights at death, in mice bearing successive passages of tumours
A ", " B " or " C " are shown in detail in Table II and summarised in Fig. 2.
In the case oftumour " A " the lymph node and thymic weights were markedly
subnormal throughout, whilst the relative spleen weights were constantly elevated.
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FIG. 1.-Mean tumour diameters at intervals, following each successive passage of tumours
" A ", " B " and " C " within the strain oforigin.
both showed a progressive decline on serial transplantation ofthe tumour, but the
sequence of changes in the spleen lagged behind that in the lymph nodes, spleno-
megaly being observed in the early transplant generations of both these tumours.
It was again observed that, whilst the lymph node weights approximated to
normal for early passages of the tumour, they became markedly subnormal in
later passages.
The thymus was either absent or markedly atrophic throughout.
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FIG. 2.- Lymph node and relative spleen weights at death in A-strain mice bearing successive
passages of tumours "A ","B "or "C "
DISCUSSION
In general the decline in relative spleen and lymph node weights, recorded at
death in mice bearing successive transplants of a given tumour, followed a similar
decline to that recorded two weeks after tumour transplantation by Woodruff
and Symes (1962). Furthermore the relative sequence of changes in the lymph
node and spleen weights at death are similar to those noted by Symes (1965) two
weeks after transplantation.
The present experiments show that on serial passage of a tumour there is a
direct relation between the decline in host immunological response, and the
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decrease in time taken by the tumour to kill the host. Also although the spon-
taneously occurring tumours " A ", " B " and " C " were each transplanted
initially when they had attained a similar size, the degree of host immunological
response to " A " and " C " was greater than that to " B " in early transplant
generations (Symes, 1965) (Table II). This suggests tumour " B " possessed less
specific antigenicity than tumours " A" or " C " and it is therefore of interest to
note the relatively shorter killing time for early transplant generations of tumour
" B ".
A correlation has thus been established between the deletion oftumour specific
antigens and increased malignancy on the part of the tumour.
Finally the atrophic condition of the lymph nodes described may serve as a
clue to the common clinical occurrence of metastases in these structures. It may
be thought that any tumour cell possessed of specific antigenicity would be des-
troyed on settling in a lymph node, but at a time when a node is no longer contri-
buting effective immunological resistance to the tumour it may serve as an excellent
collecting site for itinerant tumour cells.
SUMMARY
Three spontaneously occurring A-strain mammary carcinomata were main-
tained separately by serial transplantation in isogenic hosts.
In this way it has been shown that the degree ofspecific antigenicity possessed
by a tumour, as judged by its ability to evoke lymphoid hyperplasia, is directly
related to the survivaltime ofthe host. Thus in equivalent transplant generations
a tumour showing marked specific antigenicity takes longer to kill than a less
antigenic tumour, whilst the deletion oftumour specific antigens on serial passage
of a given tumour is associated with a progressive decline in the killing time of
that tumour.
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